JCAD, a new potential therapeutic target in cholestatic liver disease. | Clin Mol Hepatol;30(2): 166-167, 2024 Apr. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

JCAD, a new potential therapeutic target in cholestatic liver disease.

Jang, Byoung Kuk.

Affiliation

Jang BK; Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea.

Clin Mol Hepatol ; 30(2): 166-167, 2024 Apr.

Article in En | MEDLINE | ID: mdl-38454802

Subject(s)
Key words

Cholestatic liver disease; Hepatic stellate cell; Junctional protein associated with coronary artery disease; Primary biliary cholangitis

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cholestasis / Liver Diseases Limits: Humans Language: En Journal: Clin Mol Hepatol Year: 2024 Document type: Article Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cholestasis / Liver Diseases Limits: Humans Language: En Journal: Clin Mol Hepatol Year: 2024 Document type: Article Country of publication: